Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?

Cytokine Growth Factor Rev. 2020 Jun:53:63-65. doi: 10.1016/j.cytogfr.2020.05.008. Epub 2020 May 20.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Betacoronavirus / drug effects*
  • COVID-19
  • Cannabidiol / therapeutic use*
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / pathology
  • Cytokine Release Syndrome / drug therapy
  • Cytokine Release Syndrome / prevention & control
  • Humans
  • Inflammation / drug therapy*
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / pathology
  • SARS-CoV-2

Substances

  • Anti-Inflammatory Agents
  • Cannabidiol